The indigenous COVID-19 vaccine, Covaxin, can fight the Brazilian variant too, suggests a new study on the vaccine. Earlier, the vaccine was found to have the capability to fight the UK variant, B.1.1.7, and the double mutant, B.1.617.

The vaccine, developed by the Indian Council of Medical Research (ICMR) in association with Bharat Biotech, is therefore capable of fighting some of the major variants of concern (VoC), currently circulating in the country. 

Researchers from the National Institute of Virology (NIV) and the ICMR assessed the neutralization efficacy of the Brazilian variant, B.1.1.28.2, with convalescent sera of people with natural COVID infection and those who had been given two doses of Covaxin. It was noted that after receiving two doses of Covaxin, people’s immunity was boosted against the Brazilian variant… (ET Healthworld – TNN, May 3, 2021)